Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Schenone

Showing results (111-120 of 173) with videos related to

Pageof 18
Sort By:
Bioorganic & Medicinal Chemistry|September 25, 2004
Synthesis, antimicrobial activity and molecular modeling studies of halogenated 4-[1H-imidazol-1-yl(phenyl)methyl]-1,5-diphenyl-1H-pyrazolesGiulia Menozzi, Luisa Merello, Paola Fossa, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 30, 2017
The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme CellsGiada Catalogna, Cristina Talarico, Vincenzo Dattilo, et al.
Frontiers in Pharmacology|November 23, 2016
A Pyrazolo[3,4-<i>d</i>]pyrimidine Compound Reduces Cell Viability and Induces Apoptosis in Different Hematological MalignanciesIlaria Laurenzana, Antonella Caivano, Francesco La Rocca, et al.
European Journal of Medicinal Chemistry|December 9, 2008
Parallel synthesis, molecular modelling and further structure-activity relationship studies of new acylthiocarbamates as potent non-nucleoside HIV-1 reverse transcriptase inhibitorsAndrea Spallarossa, Sara Cesarini, Angelo Ranise, et al.
ACS Medicinal Chemistry Letters|March 16, 2018
Water Solubility Enhancement of Pyrazolo[3,4-<i>d</i>]pyrimidine Derivatives via Miniaturized Polymer-Drug MicroarraysMonica Sanna, Giovanna Sicilia, Ali Alazzo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 2010
New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cellsAlessandra Rossi, Silvia Schenone, Adriano Angelucci, et al.
Journal of Medicinal Chemistry|March 19, 2004
Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cellsFabio Carraro, Annalisa Pucci, Antonella Naldini, et al.
Fluids and Barriers of the CNS|August 18, 2023
Inhibition of serum- and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical modelsAlexandra Hochstetler, Hillary Smith, Makenna Reed, et al.
Molecular Cancer Therapeutics|May 20, 2016
Suppression of SRC Signaling Is Effective in Reducing Synergy between Glioblastoma and Stromal CellsAlessia Calgani, Giulia Vignaroli, Claudio Zamperini, et al.
Molecular Biosystems|March 12, 2014
Proteomics and phosphoproteomics provide insights into the mechanism of action of a novel pyrazolo[3,4-d]pyrimidine Src inhibitor in human osteosarcomaGiulia Bernardini, Marcella Laschi, Tommaso Serchi, et al.
Pageof 18

Showing results (111-120 of 173) with videos related to

Sort By:
Pageof 18
Bioorganic & Medicinal Chemistry|September 25, 2004
Synthesis, antimicrobial activity and molecular modeling studies of halogenated 4-[1H-imidazol-1-yl(phenyl)methyl]-1,5-diphenyl-1H-pyrazolesGiulia Menozzi, Luisa Merello, Paola Fossa, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 30, 2017
The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme CellsGiada Catalogna, Cristina Talarico, Vincenzo Dattilo, et al.
Frontiers in Pharmacology|November 23, 2016
A Pyrazolo[3,4-<i>d</i>]pyrimidine Compound Reduces Cell Viability and Induces Apoptosis in Different Hematological MalignanciesIlaria Laurenzana, Antonella Caivano, Francesco La Rocca, et al.
European Journal of Medicinal Chemistry|December 9, 2008
Parallel synthesis, molecular modelling and further structure-activity relationship studies of new acylthiocarbamates as potent non-nucleoside HIV-1 reverse transcriptase inhibitorsAndrea Spallarossa, Sara Cesarini, Angelo Ranise, et al.
ACS Medicinal Chemistry Letters|March 16, 2018
Water Solubility Enhancement of Pyrazolo[3,4-<i>d</i>]pyrimidine Derivatives via Miniaturized Polymer-Drug MicroarraysMonica Sanna, Giovanna Sicilia, Ali Alazzo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 2010
New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cellsAlessandra Rossi, Silvia Schenone, Adriano Angelucci, et al.
Journal of Medicinal Chemistry|March 19, 2004
Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cellsFabio Carraro, Annalisa Pucci, Antonella Naldini, et al.
Fluids and Barriers of the CNS|August 18, 2023
Inhibition of serum- and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical modelsAlexandra Hochstetler, Hillary Smith, Makenna Reed, et al.
Molecular Cancer Therapeutics|May 20, 2016
Suppression of SRC Signaling Is Effective in Reducing Synergy between Glioblastoma and Stromal CellsAlessia Calgani, Giulia Vignaroli, Claudio Zamperini, et al.
Molecular Biosystems|March 12, 2014
Proteomics and phosphoproteomics provide insights into the mechanism of action of a novel pyrazolo[3,4-d]pyrimidine Src inhibitor in human osteosarcomaGiulia Bernardini, Marcella Laschi, Tommaso Serchi, et al.
Pageof 18